ENLV icon

Enlivex Therapeutics

4 hedge funds and large institutions have $1.91M invested in Enlivex Therapeutics in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$1.77M 298,506 +26,800 +10%
Jane Street
2
Jane Street
New York
$64K 10,807 -19,904 -65%
UBS Group
3
UBS Group
Switzerland
$61K 10,230 +9,886 +2,874%
SPIA
4
Steward Partners Investment Advisory
New York
$8K 1,500 +1,500 New
CH
5
CVI Holdings
Delaware
-18,464 Closed
SM
6
Sabby Management
Florida
-12,925 Closed
Two Sigma Investments
7
Two Sigma Investments
New York
-10,971 Closed
Two Sigma Advisers
8
Two Sigma Advisers
New York
-10,100 Closed
Morgan Stanley
9
Morgan Stanley
New York
-2 Closed
CFGS
10
Concourse Financial Group Securities
Alabama